Overview

Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.

Status:
Unknown status

Trial end date:
2020-01-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to assess efficacy of 10-day antimicrobial susceptibility test guided triple therapy for the first-line treatment of Helicobacter pylori infection, then comparing it with 14-day empirical tailored therapy to tell which one has a better performance in both efficacy and safety.

Phase:

Phase 4

Details

Lead Sponsor:

Shandong University

Treatments:

Amoxicillin
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antitubercular
Bismuth
Clarithromycin
Furazolidone
Levofloxacin
Metronidazole
Ofloxacin
Pectin
Proton Pump Inhibitors
Tetracycline
Tinidazole